Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis

• 作 者: Hasan Ali Taqi Rizvi Mumtaz Niazi Mark Galan Nikolaos Pyrsopoulos
• 机 构: Department of Internal Medicine,Rutgers University New Jersey Medical School,Newark,NJ,USA;Edward Vi
• 出 处: 临床与转化肝病杂志（英文版）
• 发表日期: 2022年1期
• 关键词: Autoimmune hepatitis Syphilis Molecular mimicry

We present a unique case of biopsy-proven syphilitic hepa-titis which presented as severe acute liver injury with sig-nificant elevation in aminotransferases and bilirubin, and improved with antibiotic therapy. However, the patient re-turned weeks after initial presentation with new-onset acute liver injury and had developed hypergammaglobulinemia, positive autoantibody titers, and repeat liver biopsy dem-onstrating interface hepatitis, supporting a diagnosis of autoimmune hepatitis. He had an otherwise unrevealing etiologic workup, and responded to glucocorticoid therapy. We believe that syphilitic hepatitis and its treatment sub-sequently triggered an immunogenic response, leading to autoimmune hepatitis. Autoimmune hepatitis is a chronic liver disease thought to manifest as a result of predisposing genetic factors in combination with environmental insults, especially hepatotropic pathogens. Syphilis is a sexually transmitted disease caused by Treponema pallidum that has been associated with autoimmunity and the develop-ment of autoantibodies. We propose that in the setting of syphilitic hepatitis, a molecular mimicry event resulting from structural similarities between T. pallidum and liver antigens, as well as impaired regulatory T-cell function, led to the breakdown of immune tolerance and the onset of au-toimmune hepatitis. To support this hypothesis, further mo-lecular analyses and case series are necessary to determine if syphilitic hepatitis and its treatment are risk factors for the onset of autoimmune hepatitis. Autoimmune hepatitis should be considered early as the cause of acute liver injury in susceptible patients with risk factors for the disease, as prompt recognition and appropriate treatment may prevent progression of liver injury and result in improved outcomes.